Gamma delta (γδ) T cells hold significant potential for unmet medical needs. Yet they are more challenging to source than other T cells, representing as little as 1% to 5% of the total CD3+ T ...

New York- and Alabama-based IN8bio is leveraging gamma-delta (γδ) T cell biology to merge innate and adaptive immune capabilities against cancer. Has some of the early excitement in the cell ...

A new study published in Cell Reports Medicine reveals critical insights into the role of gamma-delta T cells across 33 ...

FLORIDA: The significance of gamma-delta T cells in 33 different cancer types is revealed in a recent study that was ...

Diagnosis. Hepatosplenic T-cell lymphoma. Management. Splenectomy, antibiotic therapy and chemotherapy with cyclophosphamide. A 58-year-old man with a 35-year history of Crohn's disease presented ...

ACE1831 is an allogeneic gamma delta T cell therapy candidate targeting CD20-expressing cells currently being investigated in non-Hodgkin's lymphoma (NHL) The planned clinical study will be executed ...

The Abingworth-backed biotech is developing therapies based on the unique properties of gamma delta (γδ) T cells, a class of lymphocytes that play a role in a host of immune responses and ...

GammaDelta’s drug platform is based on the unique properties of gamma delta (γδ) T cells, a class of lymphocytes that play a role to many types of immune responses and immunopathology.

ACE1831 utilizes bioorthogonal chemistry to link CD20-targeting antibodies to gamma delta T cells, creating an off ... escalation study for non-Hodgkin's lymphoma (NHL). "Based on the observation ...

IND clearance paves the way for Acepodia to enter the clinic for the first time with its autoimmune program ACE1831 is an allogeneic gamma delta T cell therapy ...